Home
/ BTG
/ Competitors

BTG Competitors and Similar CompaniesClear all

BTG's competitors and similar companies include Zogenix, Affimed N.V. and Avid Bioservices.

	BTG BTG is an international specialist healthcare company.	Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.	Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.	Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
Founding Date	Founding Date 1948	Founding Date 2006	Founding Date 2000	Founding Date 1981
Type	Type Subsidiary	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare clinics pharma	Tags Healthcare clinics pharma	Tags Healthcare clinics pharma	Tags Healthcare clinics pharma
Locations	Locations London, GB HQ Rosedale, AU Ottawa, CA Düsseldorf, DE Yokne'am Illit, IL see more	Locations Emeryville, US HQ Maidenhead, GB	Locations Heidelberg, DE HQ	Locations Tustin, US HQ
Employees	Employees 6501% decrease	Employees 75	Employees 76	Employees 21114% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 52.5 m	Valuation ($) 649.4 m
Financial
Revenue (est.)	Revenue (est.) £731.3m (FY, 2019)	Revenue (est.) $81.7m (FY, 2021)	Revenue (est.) €8.3m (FY, 2023)	Revenue (est.) $139.9m (FY, 2024)
Cost of goods	Cost of goods £221m (FY, 2019)	Cost of goods $4.8m (FY, 2021)	Cost of goods N/A	Cost of goods $132.6m (FY, 2024)
Gross profit	Gross profit £510.3m (FY, 2019)	Gross profit N/A	Gross profit €13m (FY, 2023)	Gross profit $7.3m (FY, 2024)
Net income	Net income £88.3m (FY, 2019)	Net income ($227.4m) (FY, 2021)	Net income (€105.9m) (FY, 2023)	Net income ($140.8m) (FY, 2024)